Monday, 25 March 2019

Lupin Limited Announced That It Has Received Approval For Its Sildenafil Tablets

Lupin Limited announced that it has received approval for its Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration to market a generic version of Pfizer Inc’s Viagra Tablets, 25 mg, 50 mg, and 100 mg.

Lupin’s Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, is the generic version Pfizer Inc’s Viagra Tablets, 25 mg, 50 mg, and 100 mg. Sildenafil Tablets are a phosphodiesterase-5 inhibitor indicated for the treatment of erectile dysfunction.

For more information +91- 6232578593 or visit www.moneymarketmanthan.com

No comments:

Post a Comment

Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India

Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...